April 13, 2022
Via: medicaldevice-network.comVersantis is set to receive nearly $508,753 (Sfr475,000) from Swiss national innovation agency Innosuisse for the development of a point-of-care (POC) device to monitor blood ammonia in liver disease patients. The company plans to enlist the Zurich University of Applied […]
July 17, 2024
Copyright © 2024. All rights reserved
